<DOC>
	<DOCNO>NCT02802384</DOCNO>
	<brief_summary>Paget 's disease bone skeletal disorder result increase disorganized bone remodeling , lead dense fragile expand bone . The identified genetic cause Paget 's disease bone explain bone destroyed , bone form place abnormal . Current treatment people Paget 's disease bone limit patient bone pain , think relate high rate bone turnover ( breakdown rebuild bone ) work slow rate bone breakdown . The current treatment address excess blood vessel bone form . This research do understand factor may promote blood vessel bone formation Paget 's disease bone .</brief_summary>
	<brief_title>Pathophysiology Paget 's Disease Bone</brief_title>
	<detailed_description>The genetic mutation find Paget 's disease currently account 15 % case limited gene affect osteoclast differentiation function . These mutation alone insufficient explain full phenotype , particularly hypervascularity increase bone formation . Through series basic science study , investigator recently find preosteoclasts secrete chemokines promote migration various stem cell , differentiate osteoblast endothelial cell support osteogenesis angiogenesis , respectively . The investigator perform cross sectional study patient active Paget 's disease bone compare similar people without Paget 's disease bone . The goal enroll 10 patient Paget 's disease bone ( case ) 10 healthy , age- sex-matched people ( control ) meet similar exclusion criterion . Participants consent study undergo brief history physical exam , allow review medical record relevant disease , one blood ( 5 tablespoon ) sample drawn . The investigator hypothesize specific chemokine concentration increase people Paget 's disease bone compare control . The investigator also hypothesize level correlate severity disease . Therefore , investigator primary objective determine serum chemokine level increase patient Paget 's disease bone . The secondary objective evaluate serum chemokine concentration correlate various marker disease activity . Findings could aid clinical monitoring patient Paget 's disease bone could provide additional therapeutic target improve treatment painful disease .</detailed_description>
	<mesh_term>Bone Diseases</mesh_term>
	<mesh_term>Osteitis Deformans</mesh_term>
	<criteria>Inclusion Criteria Cases : Men woman age 1899 year evidence active Paget 's disease bone clinically and/or radiographically define : Increased serum alkaline phosphatase increase serum collagen type 1 ctelopeptide ( CTX ) increase urinary pyridinoline diagnosis AND history least one follow signs/symptoms : Pagetoid lesion ( ) xray/CT/MRI , increase uptake radioactive substance bone scan , bone pain , fracture , hear loss , headache , hypercalcemia , bony deformity . Inclusion criterion control : Men woman age 1899 year match age within 5 year case gender NOT evidence Paget 's disease bone define : No bone pain bony deformity Normal serum alkaline phosphatase Osteosarcoma blastic bony metastasis alone Fibrous dysplasia bone Hyperostosis frontalis interna All men woman &lt; 18 year &gt; 99 year Pregnancy ( woman ) determine selfreport Current use oral contraceptive tablet DepoProveraâ„¢ ( woman ) Current use hormone replacement therapy Creatinine clearance &lt; 60 ml/min./1.73 m2 CockcroftGault base recent serum creatinine level ( great 1 year since last assessment , measure collect blood sample verify eligibility ) Current smoke tobacco use Alcohol use great 3 unit daily Use thiazolidinediones within last year Use medication know impact bone mineral metabolism , include use bisphosphonate last 11 month ; ever use teriparatide denosumab ; use calcitonin , selective estrogen receptor modulators ( SERMs ) , estrogen within past 6 month , prednisone &gt; 5 mg 10 day last three month , antiepileptic medication ( e.g . phenytoin , carbamezapine , phenobarbitol , primidone ) ; current use within past year aromatase inhibitor ; leuprolide ; histrelin History thyroid problem currently uncontrolled define recent thyroid stimulate hormone level &lt; 0.1 microIU/mL ( great 6 month since last assessment , measure collect blood sample verify eligibility ) Other know metabolic structural bone disease low bone density ( e.g . hyperparathyroidism , multiple myeloma , sarcoid granulomatous disease , celiac disease , osteopetrosis , osteomalacia , osteitis fibrosa cystica ) Other significant medical illness ( heart disease , pulmonary disease , inflammatory bowel disease , malignancy ductal carcinoma situ ( DCIS ) nonmelanoma skin cancer , rheumatologic condition include rheumatoid arthritis , systemic lupus , renal disease require dialysis , etc . ) Inability understand provide inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Paget 's Disease Bone</keyword>
	<keyword>Healthy control</keyword>
</DOC>